Enliven Therapeutics (ELVN) Selling, General & Administrative (2019 - 2026)
Enliven Therapeutics (ELVN) reported Selling, General & Administrative of $8.21 million for Q2 2026, up 15.8% from $7.09 million a year earlier and up 15.1% from the prior quarter.
Powered by 
Analysis
Enliven Therapeutics (ELVN) Selling, General & Administrative (2019 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Enliven Therapeutics' Selling, General & Administrative came in at $35.26 million, up 36.3% year-over-year; for FY2025, it came in at $33.8 million, up 42.2% from FY2024.
- Selling, General & Administrative has increased for three consecutive years, with a five-year compound annual growth rate of 28.8% (FY2020 to FY2025).
- By year, Selling, General & Administrative came in at $23.78 million in FY2024 (+25.4%), $18.96 million in FY2023 (+144.0%), $7.77 million in FY2022 (-40.2%) and $13 million in FY2021 (+36.2%).
- Five-year quarterly Selling, General & Administrative spans a low of $1.08 million in Q2 2022 and a high of $13.04 million in Q4 2025.
- Year over year, Selling, General & Administrative has now increased in each of the last 14 quarters, with growth averaging 29.9% over the last eight quarters.
- The high point for year-over-year Selling, General & Administrative in five years was Q2 2023 (growth of 358.9%); the low point was Q2 2022 (a decline of 65.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $7.14 million (Q1 2026), $13.04 million (Q4 2025) and $6.87 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Enliven Therapeutics | 3.44 Bn | 3.44 Bn | - | 8.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.21 Mn |
| Mar 31, 2026 | 7.14 Mn |
| Dec 31, 2025 | 13.04 Mn |
| Sep 30, 2025 | 6.87 Mn |
| Jun 30, 2025 | 7.09 Mn |
| Mar 31, 2025 | 6.80 Mn |
| Dec 31, 2024 | 6.17 Mn |
| Sep 30, 2024 | 5.81 Mn |
| Jun 30, 2024 | 5.78 Mn |
| Mar 31, 2024 | 6.02 Mn |
| Dec 31, 2023 | 4.82 Mn |
| Sep 30, 2023 | 4.64 Mn |
| Jun 30, 2023 | 4.95 Mn |
| Mar 31, 2023 | 4.54 Mn |
| Dec 31, 2022 | 1.97 Mn |
| Sep 30, 2022 | 3.11 Mn |
| Jun 30, 2022 | 1.08 Mn |
| Mar 31, 2022 | 1.62 Mn |
| Dec 31, 2021 | 3.48 Mn |
| Sep 30, 2021 | 3.26 Mn |
API Access
Enliven Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ELVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "ELVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ELVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();